ALISABETH THURSTON-HICKS: Open Payments
NPI 1043367634 · CANON CITY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 24 payments from 12 companies in 2025. Trend: 2023 $600 · 2024 $618 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $135 |
| ACADIA Pharmaceuticals Inc | 3 | $85 |
| Teva Pharmaceuticals USA, Inc. | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| EMD Serono, Inc. | 1 | $40 |
| Alkermes, Inc. | 2 | $39 |
| TG Therapeutics, Inc. | 1 | $35 |
| Neurelis, Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
Products named: NUPLAZID, QULIPTA, AUSTEDO XR, VRAYLAR, HYQVIA, BRIUMVI, VALTOCO, REXULTI.
Industry payments across CO — which companies pay providers there.
